This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Mar. 5, 2013





















 

Who is really prescribing that drug?
By Mike Wokasch
There was a time in the not-too-distant past when physicians were dependent on product information provided by pharmaceutical companies. Pharmaceutical companies had a prescription drug information monopoly. They controlled what product information to disclose and how to present the information to the market — almost exclusively to physicians. Information technology and the Internet facilitated easy, rapid access to product and medical information to virtually anybody willing to go online, including patients. Physicians now face a labyrinth of influences on their prescribing practices.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Community Pulse: Which of the following has the biggest impact on which drugs physicians prescribe?
ANSWER NOW


Last week's survey: Should nicotine replacement lozenges come with better handling recommendations?
SEE RESULTS




Researchers describe 1st 'functional cure' of HIV in baby
HealthDay News
A baby born two-and-a-half years ago in Mississippi with HIV is the first case of a so-called functional cure of the infection, researchers recently announced. Standard tests can no longer detect any traces of the AIDS-causing virus even though the child has discontinued HIV medication.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


AREA & ASSOCIATION NEWS


Pharmacy leaders discuss national action plan to increase patient access to pharmacists' clinical services
AzPA
Pharmacy organization leaders from across the country recently worked toward a unified, national action plan for integrating pharmacists into current and evolving healthcare delivery models. Increasing patient access to pharmacists' patient care services through value recognition allows the profession to better contribute to optimal patient health while saving healthcare dollars.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Notice: Notify the PA board of any prescribing modifications in your delegation agreement
AzPA
In order to comply with the statutory requirement of A.R.S.32-2532(J), the Arizona Regulatory Board of Physician Assistants has created a process by which physician assistants and their supervising physicians can notify the board of modifications to prescribing delegation. Please click here for more information. Please direct your questions to Lisa Wynn, executive director, Arizona Regulatory Board of Physician Assistants, Arizona Medical Board, 480-551-2898.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


April DEA Prescription Drug Take-Back Day offers consumers another opportunity for convenient medication disposal
AzPA
Consumers across the country will have another opportunity to help prevent abuse and misuse of prescription drugs by disposing of any unneeded or unwanted medications during the sixth Drug Enforcement Administration National Prescription Drug Take-Back Day, Saturday, April 27. On this day, from 10 a.m. to 2 p.m., consumers may safely dispose of unwanted medications at one of thousands of collection sites coordinated by DEA and provided by law enforcement agencies and community organizations in all 50 states and United States jurisdictions. The DEA online collection site locator will be available in April.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Arizona Department of Health Services kicks off Power Me A2Z
AzPA
Arizona Department of Health Services kicks off Power Me A2Z, a women's health campaign promoting the benefits of folic acid. Taking a multivitamin with folic acid makes your hair shine, skin glow, nails grow and protects against birth defects. Women can receive a free 90-day supply of multivitamins. For complete information visit the website.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Pharmacist and Patient-Centered Diabetes Care Certificate Training Program
AzPA
Date: April 5
The Pharmacist and Patient-Centered Diabetes Care Certificate Training Program is an innovative and intensive certificate program that focuses on the pharmacist's role in the area of diabetes management. The program, which emphasizes a healthcare team approach, seeks to foster the implementation of pharmaceutical care interventions that will promote disease self-management.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Not an AzPA member? Join today
AzPA
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PHARMACY UPDATES


Lobbyists weigh in on pharmacy oversight
The Washington Post
Drug companies are ramping up efforts on Capitol Hill to block specialty pharmacies from mass producing drugs in lightly regulated conditions, urging lawmakers to require that these enterprises return to their traditional roles or face stricter standards. Commercial drug makers are also pressing a lobbying campaign aimed at stopping these specialty pharmacies, known as compounders, from making "knockoff" drugs for people and their pets that the companies say are costing them millions of dollars in annual profits, records and interviews show.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Rhode Island Health Department shuts down pharmacy that mixed fertility drugs
The Providence Journal
In a rare move, the Rhode Island Health Department recently shut down a specialty pharmacy in Lincoln for improperly compounding fertility drugs. The department also pulled the license of its pharmacist.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE



Pharmacy chains push into healthcare
The Wall Street Journal
Pharmacy chains are branching out into healthcare services as a way to counter a slowdown in prescription drug sales and evolve beyond just dispensing pills. In the most recent development, Rite Aid Corp. will open 58 stores, across four markets that will contain in-store clinics providing virtual doctor visits conducted via webcam. The walk-in clinics — which charge patients $45 for a 10-minute chat with a doctor on a computer monitor — will be rolled out in Baltimore, Boston, Philadelphia and Pittsburgh.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Survey investigates attitudes on high-risk CSPs
Pharmacy Times
A survey carried out by the Institute for Safe Medication Practices in November and December 2012 addressed a range of issues regarding the preparation, oversight and use of high-risk compounded sterile preparations. The survey yielded responses from 412 hospital practitioners, primarily pharmacists but also including pharmacy technicians, nurses, and physicians. In the wake of the recent fungal meningitis outbreak caused by contaminated steroids, there is a great deal of concern over how to ensure compliance with sterility standards in pharmacies.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


IN THE NEWS


Study: Flu vaccine might increase narcolepsy risk in teens, children
The Blaze
A vaccine meant to protect against swine flu has been associated with an increased risk for sleep disorders among teens and children in a recent study, supporting similar conclusions of past studies as well. The study recently published in the British Medical Journal found that the A/H1N1 2009 influenza vaccine, known as Pandemrix, might be associated with narcolepsy, a disorder characterized by "excessive sleepiness and frequent daytime sleep attacks."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Father of 2 almost dies after chemist gives him diabetes drugs instead of medication for chest infection
The Daily Mail
A father of two almost died after Lloyds Pharmacy staff gave him the wrong medicine. Richard Whipps, 38, who had a chest infection, was wrongly given diabetic medication instead of steroids for asthma by his local Lloyds Pharmacy in the U.K. Although the sticker on the packet detailed the medication Whipps was supposed to have, the tablets inside were the wrong kind.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MEDICATION UPDATES


FDA OKs extended-release Abilify
MedPage Today
The FDA has approved an extended-release injectable formulation of the antipsychotic drug aripiprazole. The new formulation is the first dopamine D2 partial agonist approved as a once-monthly treatment via intramuscular injection, drug makers Otsuka and Lundbeck stated in a press release. Long-acting antipsychotic treatments help prevent relapse through missed dosing, the statement said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Stroke guideline supports expanded alteplase use
American Society of Health-System Pharmacists
A revised American Heart Association and American Stroke Association guideline on the early management of ischemic stroke seeks to build on recent gains in reducing disability and death from stroke. According to the guideline, stroke in 2008 was the fourth-leading cause of death in the United States — an improvement from previous years, when the disease ranked third. Further gains, according to AHA and ASA, require a comprehensive approach to caring for patients in the immediate aftermath of a stroke.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Ondansetron not associated with adverse fetal events
Medscape
The antiemetic drug ondansetron, taken by pregnant women for nausea and vomiting, is not associated with an increased risk for adverse fetal events, according to a study published online Feb. 27 in the New England Journal of Medicine. The researchers used Cox proportional-hazards regression models to estimate hazard ratios. They accounted for the gestational age at which adverse events occurred by using gestational age in days as a time scale in the models. They estimated propensity scores for the probability of exposure to ondansetron according to baseline characteristics of the women at pregnancy onset. They then adjusted for nausea and vomiting severity and exposure to other antiemetics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA advisers recommend 2 changes to next season's flu vaccines
American Society of Health-System Pharmacists
Advisers to the FDA recently recommended that two components of the currently licensed trivalent influenza virus vaccines be replaced for the 2014–15 influenza season. The advisers' recommendations match those recently made by the World Health Organization for Northern Hemisphere influenza vaccines for the 2013–14 flu season.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA OKs drug for postmenopausal dyspareunia
Medscape
The Food and Drug Administration has approved ospemifene for treating moderate to severe dyspareunia in postmenopausal women, the agency recently announced. Ospemifene is a novel selective estrogen-receptor modulator that makes vaginal tissue thicker and less fragile, resulting in a reduction in the amount of pain women experience with sexual intercourse. Ospemifene is taken orally with food once daily.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
March 5, 2013
Feb. 26, 2013
Feb. 19, 2013
Feb. 12, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063